Neprilysin inhibitors
US9771337B2 · kind B2 · utility
2Cited by
33References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2016 |
| Grant date | Sep 26, 2017 |
| Priority date | — |
| Expiry date | Oct 10, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09K15/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the invention relates to compounds having the formula:where R1, R2, R3, X, R4, R5, and R6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.